摘要
高血压是全球范围内的公共卫生问题。患病人数众多而诊断率、治疗率和控制率较低且分布不均衡。发展中国家面临的高血压疾病负担呈现出快速增长态势,已成为危害人群健康的主要原因之一。为改善血压控制状况,新近两项重要的国际高血压指南相继发布,为全世界范围内高血压诊治和管理提供了重要的参考。新指南的核心要义之一是强调降压治疗中药物联合的重要性,优化起始联合及单片复方制剂的推广应用是现阶段提升降压达标率和改善治疗依从性的有效途径。
Hypertension is a global public health problem.The number of patients is large,but the diagnosis rate,treatment rate and control rate are low and unevenly distributed.The burden of hypertension in developing countries shows a rapid growth trend,which has become one of the main reasons endangering people's health.In order to improve blood pressure control,two important international guidelines for hypertension have been issued one after another,which provides an important reference for the diagnosis,treatment and management of hypertension all over the world.One of the core points of the new guidelines is to emphasize the importance of drug com⁃bination in antihypertensive treatment.Optimizing the initial combination and the popularization and application of single pill combina⁃tion are effective ways to improve the control rate of antihypertensive and improve treatment compliance at present.
作者
张新军
ZHANG Xinjun(National Clinical Research Center for Geriatrics,Department of Geriatric,West China Hospital,Sichuan University,Chengdu 610041,China)
出处
《西南医科大学学报》
2022年第4期277-281,共5页
Journal of Southwest Medical University
基金
四川省卫健委基金项目(川干研ZH2020-101)。
关键词
高血压
治疗
起始联合
单片联合
Hypertension
Treatment
Initial combination
Single pill combination